Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/213469
Title: | Effect of frailty on postoperative complications, mortality, and survival in older patients with non-metastatic colon cancer: A systematic review and meta-analysis |
Author: | Moreno Carmona, Mª. Rosario Serra Prat, Mateu Riera, Stephanie A. Estrada, Óscar Ferro, Tarsila Querol, Rosa |
Keywords: | Càncer colorectal Complicacions quirúrgiques Colorectal cancer Complications of surgery |
Issue Date: | 1-Mar-2024 |
Publisher: | Elsevier BV |
Abstract: | Introduction: New evidence has emerged on the impact of frailty on prognosis in colon cancer, but the findings are not always consistent and conclusive. The aim of this systematic review was to assess the effect of frailty on postoperative complications and mortality in patients with non-metastatic colon cancer (CC) aged 65 years and older. Materials and Methods: We systematically searched for original studies published in the PubMed and Web of Science databases up to June 2021. Two independent reviewers selected the studies and extracted predefined data. A meta-analysis was performed using the random effects model to assess the effect of frailty on 30-day, 3- to 6-month and 1-year mortality, survival, and postoperative complications. Results: The search yielded 313 articles, of which 14 were included in this systematic review. The meta-analysis showed an effect for frailty on 30-day, 3- to 6-month, and 1-year mortality with respective pooled odds ratios (ORs) of 3.67 (95% confidence interval [CI] 1.53-8.79, p = 0.004), 8.73 (95% CI 4.03-18.94, p < 0.0001), and 3.99 (95% CI 2.12-7.52, p < 0.0001). Frailty also had an effect on survival, with a pooled hazard ratio of 2.99 (95% CI 1.70-5.25. p < 0.0001), and on overall and severe postoperative complications with pooled ORs of 2.34 (95% CI 1.75-3.15; p < 0.0001) and 2.43 (95% CI 1.72-3.43; p < 0.0001), respectively. Discussion: Frailty in older patients with CC is a risk factor for postoperative complications and mortality in the short term (30 days), medium term (3-6 months), and long term (1 year). |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.jgo.2023.101639 |
It is part of: | Journal of Geriatric Oncology, 2024, vol. 15, num. 2 |
URI: | https://hdl.handle.net/2445/213469 |
Related resource: | https://doi.org/10.1016/j.jgo.2023.101639 |
ISSN: | 1879-4068 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PIIS1879406823002369.pdf | 1.89 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License